Found: 4
Select item for more details and to access through your institution.
Celecoxib is a CYP1A2 inhibitor in vitro but not in vivo.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 5, p. 511, doi. 10.1007/s00228-007-0456-4
- By:
- Publication type:
- Article
Tolfenamic acid is a potent CYP1A2 inhibitor in vitro but does not interact in vivo: correction for protein binding is needed for data interpretation.
- Published in:
- European Journal of Clinical Pharmacology, 2007, v. 63, n. 9, p. 829, doi. 10.1007/s00228-007-0335-z
- By:
- Publication type:
- Article
In vitro Inhibition of CYP1A2 by Model Inhibitors, Anti-Inflammatory Analgesics and Female Sex Steroids: Predictability of in vivo Interactions.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2008, v. 103, n. 2, p. 157, doi. 10.1111/j.1742-7843.2008.00252.x
- By:
- Publication type:
- Article
Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 62, n. 3, p. 345, doi. 10.1111/j.1365-2125.2006.02653.x
- By:
- Publication type:
- Article